![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
National Taiwan University Hospital |
---|---|
Information provided by: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00172250 |
Elevation of plasma homocysteine has been recognized as one of the risk factors of atherosclerotic disease. The objectives of this study are: (1) to investigate the level of plasma homocysteine and the prevalence of hypehomocysteinemia (2) to find out the role of homocysteine in coronary artery disease and the proper cut-off point of plasma homocysteine to evaluate the presence of coronary artery disease; (3) to understand the control condition of tranditional risk factors of cardiovascular disease, especially hypertension, dyslipidemia, and diabetes mellitus.
The study subjects were recruited from the ambulatory setting of cardiology in National Taiwan University Hospital.
Condition |
---|
Homocysteine Coronary Artery Disease |
Study Type: | Observational |
Study Design: | Screening, Cross-Sectional, Case Control, Retrospective Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Patient > 65 y/o or < 50y/o Scr<=1.5mg/dL
Exclusion Criteria:
Study ID Numbers: | 9261701046 |
Study First Received: | September 12, 2005 |
Last Updated: | November 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00172250 |
Health Authority: | Taiwan: Department of Health |
Atherosclerosis Arterial Occlusive Diseases Heart Diseases Myocardial Ischemia Vascular Diseases Central Nervous System Diseases Ischemia |
Arteriosclerosis Brain Diseases Cerebrovascular Disorders Folic Acid Coronary Disease Carotid Artery Diseases Coronary Artery Disease |
Nervous System Diseases Cardiovascular Diseases |